|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 109.90 BDT | +1.29% |
|
+5.07% | +5.07% |
| Market Cap | 25.39B 207M 180M 167M 156M 293M 19.5B 295M 1.98B 767M 9.6B 776M 759M 33.33B | P/E 2024 |
68.2x | P/E 2025 | 25.8x |
|---|---|---|---|---|---|
| Enterprise Value | 35.35B 288M 251M 232M 218M 408M 27.15B 410M 2.76B 1.07B 13.36B 1.08B 1.06B 46.4B | EV / Sales 2024 |
4.25x | EV / Sales 2025 | 2.74x |
| Free-Float |
36.94% | Yield 2024 |
1.3% | Yield 2025 | 1.98% |
| 1 day | +1.29% | ||
| 1 week | +5.07% | ||
| Current month | +8.06% | ||
| 1 month | +8.70% | ||
| 3 months | +7.85% | ||
| 6 months | +7.64% | ||
| Current year | +5.07% |
| 1 week | 105.2 |  | 115 |
| 1 month | 100.4 | | 115 |
| Current year | 96 | | 115 |
| 1 year | 96 | | 147.5 |
| 3 years | 92.4 | | 288.9 |
| 5 years | 92.4 | | 393 |
| 10 years | 16 | | 393 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ulfat Karim
CEO | Chief Executive Officer | - | - |
| Director of Finance/CFO | - | - | |
| Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 66 | - | |
| Director/Board Member | 42 | - | |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.29% | +5.07% | +5.88% | -55.14% | 207M | |
| -1.21% | -3.04% | +39.94% | +145.38% | 980B | |
| -2.48% | -5.18% | +51.52% | +39.07% | 550B | |
| -2.14% | -4.94% | +16.71% | +56.15% | 382B | |
| +0.25% | -3.09% | +23.00% | +15.81% | 317B | |
| +0.61% | -1.69% | +25.42% | +13.64% | 270B | |
| +0.22% | -3.10% | +24.25% | +30.21% | 269B | |
| +4.59% | +1.98% | -40.02% | -45.89% | 191B | |
| -1.19% | -4.95% | +16.56% | +47.00% | 182B | |
| -1.35% | -1.46% | +14.59% | +56.94% | 154B | |
| Average | -0.14% | -2.94% | +17.79% | +30.32% | 329.42B | |
| Weighted average by Cap. | -0.79% | -3.67% | +27.97% | +63.97% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 10.7B 87.11M 75.95M 70.34M 65.85M 124M 8.22B 124M 835M 323M 4.05B 327M 320M 14.05B | 12.54B 102M 89.02M 82.45M 77.18M 145M 9.63B 146M 978M 379M 4.74B 383M 375M 16.47B |
| Net income | 521M 4.24M 3.7M 3.42M 3.21M 6.01M 400M 6.05M 40.63M 15.75M 197M 15.92M 15.58M 684M | 947M 7.7M 6.72M 6.22M 5.82M 10.92M 727M 10.99M 73.81M 28.6M 358M 28.92M 28.3M 1.24B |
| Net Debt | 10B 81.37M 70.95M 65.71M 61.51M 115M 7.68B 116M 780M 302M 3.78B 305M 299M 13.12B | 9.96B 81.1M 70.71M 65.49M 61.31M 115M 7.65B 116M 777M 301M 3.77B 304M 298M 13.08B |
Employees
4,771
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/06/26 | 109.90 BDT | +1.29% | 407,949 |
| 17/06/26 | 108.50 BDT | -0.18% | 387,118 |
| 16/06/26 | 108.70 BDT | -2.16% | 701,976 |
| 15/06/26 | 111.10 BDT | -1.42% | 858,592 |
| 14/06/26 | 112.70 BDT | +7.74% | 1,749,001 |
- Stock Market
- Stocks
- BEACONPHAR Stock
Select your edition
All financial news and data tailored to specific country editions
